Endocrinology Advisor3d
Gemtesa Approved for Men With OAB Symptoms Receiving BPH Treatment
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Consumer Reports1mon
Why you should be wary of the Oxytrol patch
The Oxytrol for Women (oxybutynin) patch is available without a prescription to treat those with an overactive bladder, which can cause incontinence problems and make women run to the bathroom ...
FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...